These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 15035110

  • 1. [Adhesion molecules in the context with bone remodeling and osteoporosis].
    Tanaka Y.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():125-30. PubMed ID: 15035110
    [No Abstract] [Full Text] [Related]

  • 2. [Recent advances in basic research of bone metabolism].
    Inoue D, Matsumoto T.
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():25-33. PubMed ID: 11979916
    [No Abstract] [Full Text] [Related]

  • 3. [Recent advances in the regulation of bone remodeling].
    Matsumoto T.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():37-46. PubMed ID: 15035093
    [No Abstract] [Full Text] [Related]

  • 4. [Regulatory mechanism of osteoclast differentiation and function].
    Okumura S, Udagawa N, Takahashi N.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():90-6. PubMed ID: 15035103
    [No Abstract] [Full Text] [Related]

  • 5. [LPS].
    Miyaura C.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():116-9. PubMed ID: 15035108
    [No Abstract] [Full Text] [Related]

  • 6. [Recent advances in research of bone resorption].
    Inoue D.
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():48-56. PubMed ID: 11979946
    [No Abstract] [Full Text] [Related]

  • 7. [Recent advance in basic research for osteoporosis].
    Suda T, Miyaura C.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():13-20. PubMed ID: 15035090
    [No Abstract] [Full Text] [Related]

  • 8. [Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?].
    Ferrer Cañabate J, Tovar I, Martínez P.
    An Med Interna; 2002 Aug; 19(8):385-88. PubMed ID: 12244784
    [No Abstract] [Full Text] [Related]

  • 9. [Osteoclastogenesis inhibitory factor/osteoprotegerin(OCIF/OPG)].
    Tomoyasu A, Higashio K.
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():560-5. PubMed ID: 15035190
    [No Abstract] [Full Text] [Related]

  • 10. [Crosstalk between the immune and skeletal system].
    Takayanagi H.
    Ryumachi; 2003 Oct; 43(4):624-31. PubMed ID: 14598653
    [No Abstract] [Full Text] [Related]

  • 11. [Osteoclastogenesis Inhibitory Factor (OCIF) /Osteoprotegerin (OPG) as a new therapeutic agent for osteoporosis].
    Mochizuki S, Kiyokawa A, Nagayama Y.
    Clin Calcium; 2005 Jan; 15(1):35-42. PubMed ID: 15632471
    [Abstract] [Full Text] [Related]

  • 12. [Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases].
    Hofbauer LC, Heufelder AE.
    Dtsch Med Wochenschr; 2001 Feb 09; 126(6):145-50. PubMed ID: 11233883
    [No Abstract] [Full Text] [Related]

  • 13. The role of the immune system in the pathophysiology of osteoporosis.
    Clowes JA, Riggs BL, Khosla S.
    Immunol Rev; 2005 Dec 09; 208():207-27. PubMed ID: 16313351
    [Abstract] [Full Text] [Related]

  • 14. Genetic control of bone remodeling--insights from a rare disease.
    Krane SM.
    N Engl J Med; 2002 Jul 18; 347(3):210-2. PubMed ID: 12124412
    [No Abstract] [Full Text] [Related]

  • 15. [Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects].
    Ueland T, Bollerslev J, Mosekilde L.
    Ugeskr Laeger; 2002 Jul 01; 164(27):3526-30. PubMed ID: 12116680
    [Abstract] [Full Text] [Related]

  • 16. [Recent progress of bone cell culture system (review)].
    Koshihara Y.
    Nihon Rinsho; 2002 Mar 01; 60 Suppl 3():79-87. PubMed ID: 11979973
    [No Abstract] [Full Text] [Related]

  • 17. [OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)].
    Inoue D.
    Nihon Rinsho; 2004 Feb 01; 62 Suppl 2():102-6. PubMed ID: 15035105
    [No Abstract] [Full Text] [Related]

  • 18. [The cytokine system of bone tissue].
    Stilgren LS, Abrahamsen B, Abdallah BM, Jørgensen NR.
    Ugeskr Laeger; 2005 Feb 21; 167(8):874-8. PubMed ID: 15789838
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of bone cell development and function: implication for renal osteodystrophy.
    Disthabanchong S, González EA.
    J Investig Med; 2001 May 21; 49(3):240-9. PubMed ID: 11352181
    [No Abstract] [Full Text] [Related]

  • 20. Direct and indirect estrogen actions on osteoblasts and osteoclasts.
    Zallone A.
    Ann N Y Acad Sci; 2006 Apr 21; 1068():173-9. PubMed ID: 16831916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.